ZYME(Zymeworks Inc.) 的财务报表:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $26.68M | $412.48M | $76.01M | $76.30M | $105.97M |
| 毛利润 | — | — | — | — | — |
| 营业利润 | −$215.63M | $130.53M | −$138.05M | −$137.11M | −$92.55M |
| 净利润 | −$211.84M | $124.34M | −$118.67M | −$122.69M | −$81.13M |
| 经营现金流 | −$192.45M | $144.11M | −$118.32M | −$110.06M | −$33.01M |
| 自由现金流 | −$204.85M | $135.96M | −$120.80M | −$112.05M | −$34.53M |
| 摊薄每股收益 | $-4.61 | $1.90 | $-1.72 | $-1.62 | $-1.08 |